132 related articles for article (PubMed ID: 21789868)
1. Uses of a familial adenomatous polyposis registry.
Dalpatadu KU; Anwar N; Wijesuriya SR; Kumarage SK; Amarasinghe B; Deen KI
Ceylon Med J; 2011 Jun; 56(2):66-9. PubMed ID: 21789868
[TBL] [Abstract][Full Text] [Related]
2. Clinical characterization and mutation spectrum in Hispanic families with adenomatous polyposis syndromes.
Cruz-Correa M; Diaz-Algorri Y; Mendez V; Vazquez PJ; Lozada ME; Freyre K; Lathroum L; Gonzalez-Pons M; Hernandez-Marrero J; Giardiello F; Rodriguez-Quilichini S
Fam Cancer; 2013 Sep; 12(3):555-62. PubMed ID: 23460355
[TBL] [Abstract][Full Text] [Related]
3. The natural history of familial adenomatous polyposis syndrome: a 24 year review of a single center experience in screening, diagnosis, and outcomes.
Kennedy RD; Potter DD; Moir CR; El-Youssef M
J Pediatr Surg; 2014 Jan; 49(1):82-6. PubMed ID: 24439586
[TBL] [Abstract][Full Text] [Related]
4. Clinical analysis of eight kindreds of familial adenomatous polyposis.
He YL; Zhang CH; Huang MJ; Cai SR; Zhan WH; Wang JP; Wang JF
World J Gastroenterol; 2004 Dec; 10(24):3659-61. PubMed ID: 15534926
[TBL] [Abstract][Full Text] [Related]
5. Congenital hypertrophy of retinal pigment epithelium (CHRPE) in patients with familial adenomatous polyposis (FAP); a polyposis registry experience.
Nusliha A; Dalpatadu U; Amarasinghe B; Chandrasinghe PC; Deen KI
BMC Res Notes; 2014 Oct; 7():734. PubMed ID: 25326340
[TBL] [Abstract][Full Text] [Related]
6. Colorectal Cancer in Individuals With Familial Adenomatous Polyposis, Based on Analysis of the Danish Polyposis Registry.
Karstensen JG; Burisch J; Pommergaard HC; Aalling L; Højen H; Jespersen N; Schmidt PN; Bülow S
Clin Gastroenterol Hepatol; 2019 Oct; 17(11):2294-2300.e1. PubMed ID: 30743005
[TBL] [Abstract][Full Text] [Related]
7. Results of national registration of familial adenomatous polyposis.
Bülow S
Gut; 2003 May; 52(5):742-6. PubMed ID: 12692062
[TBL] [Abstract][Full Text] [Related]
8. [Prognosis in familial adenomatous polyposis. Results from the Polyposis Registry].
Bülow C; Bülow S; Nielsen TF; Karlsen L; Moesgaard FA
Ugeskr Laeger; 1996 Jul; 158(29):4188-90. PubMed ID: 8701535
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of familial adenomatous polyposis in Sweden: changes over time and differences in phenotype between males and females.
Björk J; Akerbrant H; Iselius L; Alm T; Hultcrantz R
Scand J Gastroenterol; 1999 Dec; 34(12):1230-5. PubMed ID: 10636071
[TBL] [Abstract][Full Text] [Related]
10. The impact of screening and genetic registration on mortality and colorectal cancer incidence in familial adenomatous polyposis.
Mallinson EK; Newton KF; Bowen J; Lalloo F; Clancy T; Hill J; Evans DG
Gut; 2010 Oct; 59(10):1378-82. PubMed ID: 20660077
[TBL] [Abstract][Full Text] [Related]
11. Centralized registration, prophylactic examination, and treatment results in improved prognosis in familial adenomatous polyposis. Results from the Danish Polyposis Register.
Bülow S; Bülow C; Nielsen TF; Karlsen L; Moesgaard F
Scand J Gastroenterol; 1995 Oct; 30(10):989-93. PubMed ID: 8545620
[TBL] [Abstract][Full Text] [Related]
12. Familial adenomatous polyposis.
de Silva DC; Fernando R
Ceylon Med J; 1998 Jun; 43(2):99-105. PubMed ID: 9704551
[TBL] [Abstract][Full Text] [Related]
13. Does early colectomy increase desmoid risk in familial adenomatous polyposis?
Durno C; Monga N; Bapat B; Berk T; Cohen Z; Gallinger S
Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1190-4. PubMed ID: 17916546
[TBL] [Abstract][Full Text] [Related]
14. [Familial adenomatous polyposis. Initial experiences with the Heidelberg polyposis register].
Möslein G; Buhr HJ; Kadmon M; Herfarth C
Chirurg; 1992 Apr; 63(4):327-33. PubMed ID: 1317773
[TBL] [Abstract][Full Text] [Related]
15. Ophthalmic and genetic screening in pedigrees with familial adenomatous polyposis.
Ruhswurm I; Zehetmayer M; Dejaco C; Wolf B; Karner-Hanusch J
Am J Ophthalmol; 1998 May; 125(5):680-6. PubMed ID: 9625552
[TBL] [Abstract][Full Text] [Related]
16. Familial adenomatous polyposis at the Tel Aviv Medical Center: demographic and clinical features.
Rozen P; Samuel Z; Rabau M; Goldman G; Shomrat R; Legum C; Orr-Urtreger A
Fam Cancer; 2001; 1(2):75-82. PubMed ID: 14574001
[TBL] [Abstract][Full Text] [Related]
17. Congenital hypertrophy of retinal pigment epithelium (CHRPE) as a marker for familial adenomatous polyposis (FAP).
Bertario L; Bandello F; Rossetti C; Sala P; Fortini E; Spinelli P; Gennari L; Pietroiusti M; Presciuttini S
Eur J Cancer Prev; 1993 Jan; 2(1):69-75. PubMed ID: 8381318
[TBL] [Abstract][Full Text] [Related]
18. Congenital hypertrophy of the retinal pigment epithelium serves as a clinical marker in a family with familial adenomatous polyposis.
Parisi ML
J Am Optom Assoc; 1995 Feb; 66(2):106-12. PubMed ID: 7714311
[TBL] [Abstract][Full Text] [Related]
19. The value of screening and central registration of families with familial adenomatous polyposis. A study of 82 families in The Netherlands.
Vasen HF; Griffioen G; Offerhaus GJ; Den Hartog Jager FC; Van Leeuwen-Cornelisse IS; Meera Khan P; Lamers CB; Van Slooten EA
Dis Colon Rectum; 1990 Mar; 33(3):227-30. PubMed ID: 2155763
[TBL] [Abstract][Full Text] [Related]
20. Genotype and phenotype factors as determinants of desmoid tumors in patients with familial adenomatous polyposis.
Bertario L; Russo A; Sala P; Eboli M; Giarola M; D'amico F; Gismondi V; Varesco L; Pierotti MA; Radice P;
Int J Cancer; 2001 Mar; 95(2):102-7. PubMed ID: 11241320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
